Availability of Animal-Free Antibodies

Animal-free antibodies are available from the sources listed below. Most companies offer a selection of catalog antibodies and custom antibody development, and generate antibody fragments and full immunoglobulin format. Note that this list is not comprehensive and that a number of the suppliers listed sell animal-derived antibodies in addition to animal-free recombinant antibodies.

Abcalis offers animal-free recombinant monoclonal antibodies and multiclonal antibodies produced in animal-serum free media.

Abcam produces a selection of antibodies using phage display recombinant antibody technology.

Adimab offers therapeutic antibody discovery and an antibody discovery platform transfer service.

AdipoGen Life Sciences generates and characterises animal-free recombinant monoclonal antibodies (RecMAbs™).

AvantGen provides a complete antibody discovery service using human antibody libraries.

Bio-Rad uses its Human Combinatorial Antibody Libraries (HuCAL) library to offer animal-free recombinant monoclonal antibodies. Catalog HuCAL antibodies can be found here by searching the HuCAL isotype.

Charles River offers antibody discovery using a human antibody library and a single domain library.

Creative Diagnostics and Creative BioMart offer limited catalog animal-free recombinant antibodies.

The Geneva Antibody Facility develops animal-free recombinant antibodies at the University of Geneva and makes them available to the scientific community. Its ABCD (AntiBodies Chemically Defined) database is a curated depository of sequenced antibodies developed at the facility.

GenScript generates antibodies produced from customer-provided sequences.

The Human Antibody Core Facility at the Oklahoma Medical Research Foundation produces antibodies from human immune responses after vaccination.

IONTAS offers custom antibody discovery.

ProMab Biotechnologies develops animal-free recombinant antibodies from a human Fab library.

The Protein Capture Reagents Program includes a database listing antibodies developed by the Recombinant Antibody Network, a consortium of centers at the University of Chicago, University of California San Francisco, and the University of Toronto. Because both animal-derived antibodies and animal-free antibodies are listed in the database, the user much search for antibodies derived from phage-displayed fragment antigen-binding (Fab) libraries.

Specifica uses its own and custom libraries and a combined phage and yeast protocol to produce antibodies in the nanomolar and sub-nanomolar range.

YUMAB uses libraries containing naturally derived antibody sequences or custom libraries to develop fully human, therapeutic antibodies.